Frontiers | Extracellular Matrix Patches for Endarterectomy Repair
SciELO - Brasil - D2-40, a novel lymphatic endothelial marker: identification of lymphovascular invasion and relationship with axillary metastases in breast cancer D2-40, a novel lymphatic endothelial marker: identification of lymphovascular invasion
The optimum marker for the detection of lymphatic vessels (Review)
Články a aktuality: Články a aktuality 2012 - 2018
Pathology Outlines - D2-40 (Podoplanin)
Double immunostaining. Cluster of tumor cells within a D2-40-stained... | Download Scientific Diagram
Pathology Outlines - D2-40 (Podoplanin)
D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells | Modern Pathology
Pathology Outlines - D2-40 (Podoplanin)
Lifastuzumab Vedotin Overview - Creative Biolabs
Pathology Outlines - D2-40 (Podoplanin)
D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans | Modern Pathology
Lymfadenopatia
Uzlinový syndrom - Zdraví.euro.cz
Uzlinový syndrom – diferenciální diagnostika - Zdraví.euro.cz
Cureus | Prognostic Significance of Lymphovascular Invasion Detected by D2- 40 in Low-Risk Stage II Colon Cancer | Article
Tumour cells express functional lymphatic endothelium-specific hyaluronan receptor in vitro and in vivo: Lymphatic mimicry promotes oral oncogenesis? | Oncogenesis
D2-40 Antibody - Biocare Medical
DIFERENCIÁLNÍ DIAGNOSTIKA KRČNÍHO UZLINOVÉHO SYNDROMU
D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma - ScienceDirect
A New Monoclonal Antibody, D2-40, for Detection of Lymphatic Invasion in Primary Tumors | Laboratory Investigation
Immunopositivity for lymphatic endothelial marker D2-40 (podoplanin) in... | Download Scientific Diagram
Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix | Modern Pathology
Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis | BMC Cancer | Full Text
Immunopositivity for lymphatic endothelial marker D2-40 (podoplanin) in... | Download Scientific Diagram
Prezentace aplikace PowerPoint
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
